Deutsche Bank Defends Waters Corp (WAT), Says Buy Recent Weakness
More News related to WAT
- Waters Spotlights ACQUITY UPLC, a Driving Force Moving the Analytical Science Industry Forward at HPLC 2009
- David Moenning's Daily State of the Markets: 6/22
- Baird Upgrades Waters (WAT) to Outperform
- Battle Road Research Expands Healthcare Coverage and Launches Blog
- First ASMS Hites Award for Outstanding Research Publication Presented to Prof. Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Protein Complexes
Deutsche Bank comments on Waters Corp. (NYSE: WAT) following the 15% sell-off over the last several weeks. The firm said the stock is now trading at a forward P/E (14x) not seen since the merger of Pfizer / Pharmacia in 2003. They said investors' fears have become irrational after Q4 results disappointed slightly.
The said the primary investors concern, that big pharma demand is deteriorating, is completely unfounded.
The firm is reiterating their Buy rating, citing valuation, saying they would be aggressive at current levels. [LJ]
Related Categories
Analyst CommentsStocks Mentioned
-22.54Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
